Universe Pharmaceuticals Inc (UPC) — Cash Flow Reinvestment Rate
Universe Pharmaceuticals Inc (UPC) has a Cash Flow Reinvestment Rate of 0.04x as of March 2025, reinvesting $96.78K (capex $96.78K ) from operating cash flow of $2.56 Million. Explore Universe Pharmaceuticals Inc (UPC) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Universe Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Universe Pharmaceuticals Inc across 4 annual periods. Also explore Universe Pharmaceuticals Inc (UPC) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Universe Pharmaceuticals Inc (2018–2023)
Year-by-year capital reinvestment analysis for Universe Pharmaceuticals Inc. For live market cap and broader valuation context, see Universe Pharmaceuticals Inc (UPC) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.08x | $88.34K | $1.12 Million | $44.17K | ▲ +365.6% |
| 2020 | 0.02x | $103.60K | $6.12 Million | $51.80K | ▲ +29.8% |
| 2019 | 0.01x | $172.36K | $13.20 Million | $86.32K | ▼ -80.0% |
| 2018 | 0.07x | $290.19K | $4.46 Million | $145.09K | — |